FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 1 |
| Recalls | 0 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | June 8, 2026 |
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. VivioMD Group LLC dba VivioMD has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Enforcement history
On 2026-06-08, Argus HQ recorded an FDA Warning Letter for VivioMD Group LLC dba VivioMD, rated "critical" severity in Argus HQ's classification: VivioMD Group LLC dba VivioMD — False & Misleading Claims/Misbranded (Telehealth) (2026-06-08). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Frequently asked questions
- Does Argus HQ track new FDA actions for VivioMD Group LLC dba VivioMD automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to VivioMD Group LLC dba VivioMD is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for VivioMD Group LLC dba VivioMD?
- 1 total: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
- What is the most recent FDA action on file for VivioMD Group LLC dba VivioMD?
- June 8, 2026. Argus HQ ingests new FDA enforcement records daily.
- Has VivioMD Group LLC dba VivioMD received FDA warning letters?
- Yes, 1 warning letter on file. See the full history below for each one.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
- VivioMD Group LLC dba VivioMD vs Philips North America
- VivioMD Group LLC dba VivioMD vs Medline Industries, LP
- VivioMD Group LLC dba VivioMD vs Boston Scientific Corporation
- VivioMD Group LLC dba VivioMD vs Baxter Healthcare Corporation
- VivioMD Group LLC dba VivioMD vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: Jun 8, 2026Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Actions Against VivioMD Group LLC dba VivioMD. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/viviomd-group-llc-dba-viviomd
"FDA Actions Against VivioMD Group LLC dba VivioMD." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/viviomd-group-llc-dba-viviomd.
Argus HQ Research. "FDA Actions Against VivioMD Group LLC dba VivioMD." Digital Empire Holdings LLC. Accessed August 29, 2026. https://argushq.ai/company/viviomd-group-llc-dba-viviomd.
@misc{argushq_argushq_ai_company_viviomd_group_llc_dba_viviomd_2026,
title = {FDA Actions Against VivioMD Group LLC dba VivioMD},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/viviomd-group-llc-dba-viviomd},
note = {Accessed: August 29, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗

